NEW YORK, NY--(Marketwire - Nov 26, 2012) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is currently seeking approval by the FDA for Northera, which helps prevent dizziness in people with central nervous system disorders. In February, a FDA advisory panel voted 7-4 in favor of approval.
Find out more about Chelsea Therapeutics including full access to the free equity report at: www.BedfordReport.com/CHTP
Groupon Inc. (NASDAQ: GRPN) shares of the discount e-commerce company have fallen over 80 percent year-to-date. The company has struggled internationally with a sales growth of just 3.1% year-over-year, after a 31% growth in the second quarter.
Find out more about Groupon including full access to the free equity report at: www.BedfordReport.com/GRPN
Jaguar Mining Inc. (NYSE: JAG) (TSX: JAG) shares of the junior gold miner have fallen nearly 90 percent year-to-date. The company has lowered their fiscal 2012 gold production guidance to 100,000 to 110,000 ounces.
Find out more about Jaguar Mining including full access to the free equity report at: www.BedfordReport.com/JAG
Zalicus Inc. (NASDAQ: ZLCS) shares of the biopharmaceutical company have fallen nearly 20 percent in the last month. Analysts' at both MLV Capital and Rodman & Renshaw have downgraded the company's rating.
Find out more about Zalicus including full access to the free equity report at: www.BedfordReport.com/ZLCS
Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release.